Cancer
New Study Reveals Communication Gaps and Urges Shared Decision-Making in Lung Cancer Care Across Europe
In a groundbreaking survey unveiled at the International Association for the Study of Lung Cancer 2025 World Conference on Lung...
Surgery Following EGFR TKI Therapy Shows Potential to Extend Progression-Free Survival in Metastatic NSCLC
(Barcelona, Spain, September 9, 2025, 10:15 a.m. CEST / UTC +2) — Groundbreaking findings from a randomized Phase II clinical...
FANSS Study Validates Feasibility of Lung Cancer Screening for Asian Female Nonsmokers in the U.S.
In recent years, the landscape of lung cancer diagnosis and screening has witnessed a significant paradigm shift, particularly in recognizing...
Boosting Sorafenib Efficacy via Dipeptidyl Peptidase 9 Inhibition
Recent advances in the understanding of hepatocellular carcinoma (HCC), a prevalent form of liver cancer, have highlighted the need for...
AI Models Enhance Prediction of Chronic Kidney Disease Progression to End-Stage Renal Disease, New Study Finds
Chronic kidney disease (CKD) represents a progressive and intricate medical condition characterized by the gradual deterioration of renal function over...
New Open-Source Data Platform Launched to Advance Lung Cancer Genetics Research
In a groundbreaking development poised to accelerate lung cancer research, the 23andMe Research Institute, in collaboration with Troper Wojcicki Philanthropies...
Overcoming Resistance Mutations and the Blood–Brain Barrier: Major Challenges in Targeted Therapy for Brain Metastases in Non-Small Cell Lung Cancer
In a groundbreaking review published in Acta Pharmaceutica Sinica B, researchers have shed new light on the formidable challenges faced...
Moffitt Creates First Genetically Engineered Cancer Model in Naked Mole Rats
In a groundbreaking advancement that challenges long-standing beliefs about cancer resistance, researchers at Moffitt Cancer Center have successfully developed the...
IU Scientists Reengineer Cancer-Protective Regulatory T Cells to Combat Tumors
Indiana University School of Medicine researchers have pioneered an innovative approach to cancer immunotherapy by reprogramming a specific subset of...
How Chemotherapy Interferes with the Body’s Internal Clock
The relentless fight against cancer has long been marked by the harsh reality of treatment-related side effects, many of which...
Groundbreaking Clinical Trial Shows Safety and Molecular Insights of Pre- and Post-Surgery Immunotherapy Combo in Operable Mesothelioma Patients
In a pioneering advancement that could reshape the therapeutic landscape for operable mesothelioma, researchers at the Johns Hopkins Kimmel Cancer...
New Study on High-Grade Serous Carcinomas in Cervical Biopsies Supports Removal of Cervical Serous Carcinoma from WHO Classification
In a groundbreaking clinicopathologic study recently published in the Journal of Clinical and Translational Pathology, researchers have shed critical light...
Cancer Cells Exploit Alternative Pathways to Sustain Their Growth
In the ever-evolving landscape of cancer metabolism, new insights often challenge long-standing paradigms about how malignant cells sustain their aggressive...
Tarlatamab Combined with Anti-PD-L1 Shows Promising Safety and Unprecedented Overall Survival as First-Line Maintenance Therapy Following Chemo-Immunotherapy in ES-SCLC
In a significant advancement within the landscape of lung cancer therapeutics, novel clinical data unveiled at the 2025 International Association...
“‘Rogue’ DNA Circles Uncover Earliest Insights into Deadly Brain Cancer Development”
‘Rogue’ DNA Rings Offer Groundbreaking Insights into Early Development and Aggressiveness of Glioblastoma A pioneering international research effort has uncovered...
Major Data Updates and New Study Broaden the Kids First Data Ecosystem
The Gabriella Miller Kids First Pediatric Research Program (Kids First) at the National Institutes of Health (NIH) has once again...
BMS-986504 Shows Lasting Efficacy in MTAP-Deleted NSCLC, Targeting EGFR and ALK-Positive Tumors
In a groundbreaking development in the fight against non-small cell lung cancer (NSCLC), researchers have unveiled promising results from a...
EA5181 Phase 3 Trial Shows No Overall Survival Advantage for Concurrent Plus Consolidative Durvalumab Over Consolidation Alone in Unresectable Stage 3 NSCLC
(Barcelona, Spain – September 8, 2025, 10:45 a.m. CEST / UTC +2) — In a pivotal development presented at the...
Video-Assisted Thoracoscopy Surgery Lowers Mortality by 21% Compared to Lobectomy
Minimally Invasive Surgery in Early-Stage Lung Cancer Demonstrates Significant Survival Advantage Over Traditional Methods Barcelona, Spain – In a landmark...
Phase III Trial Shows Hypofractionated Radiotherapy Plus Chemotherapy Matches Survival Rates and Reduces Toxicity Compared to Conventional Treatment in Limited-Stage SCLC
(Barcelona, Spain — September 8, 2025) — A pivotal multi-center, randomized phase III clinical trial has recently demonstrated that a...
